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Background
• Triple Negative Breast Cancer (TNBC) is the most 
aggressive subtype of breast cancer, with a high 
rate of metastasis and poor clinical outcome.
• Breast Cancer Stem-like Cells (BCSC) comprise a 
small portion of the primary tumor that contribute 
to the aggressive phenotype of TNBC1,2.
• BCSC have characteristics that allow them to 
proliferate, metastasize, and resist conventional 
cancer treatments. 
• There are currently no drugs that target BCSCs.
• Expression of ganglioside GD2 identifies BCSCs 
and the enzyme GD3 Synthase (GD3S) is 
upregulated in GD2+ BCSCs1.
• GD3S is a key enzyme involved in the 
biosynthesis of b- and c- series gangliosides 
including GD2.
• Inhibition of GD3S expression in TNBC cells 
significantly inhibits their stem-cell function and 
inhibits tumor growth in vivo.
Hypothesis
• Targeting GD3S enzyme activity using small-
molecule inhibitors inhibits tumor growth and 
metastasis in TNBC.
Methods
• Using a structural homology modeling approach, 
we identified cephalothin (an FDA-approved 
antimicrobial agent) as a potential GD3S 
inhibitor3.
• TNBC cell lines including SUM159 and MDA-
MB-231 were treated with cephalothin and its 
analogs at different concentrations for 72 hrs. and 
GD2 expression was analyzed using flow 
cytometry.
• TNBC cell lines treated with cephalothin, and its 
analogs were subjected to BCSC functional assay 
including mammosphere formation assay.
Results
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Figure 3: Flow cytometry dot plots showing the effect of (A.) cephalothin analog 3 and (B.) cephalothin analog 6 on SUM159. A
dose dependent decrease is observed for both analogs. Analogs 3 and 6 decreased GD2 expression by 3-fold.
Figure 4: Comparison of all six cephalothin analogs on
SUM159 cells. This graph depicts flow cytometry analysis of
% GD2 expression. Analogs 3-6 shows a dose dependent




Effect of Analogs on SUM159
• Cephalothin inhibited mammosphere formation 
in a dose dependent manor, limiting the BCSC 
function of SUM159.
• Cephalothin has shown the most significant 
decrease on GD2 expression out of the analogs 
that were tested. 
• Cephalothin analogs were more effective at 
reducing the GD2 expression in TNBC cell 
lines with higher GD2 expression such as 
SUM159 compared to MDA-MB-231 with 
lower GD2 expression.
• Cephalothin analogs 3 and 4 were the most 
effective on SUM159 cells, decreasing GD2 
expression by 3- and 4- fold, respectively.
• Cephalothin’s ability to decrease GD2  
expression makes it a potential leading 
compound for inhibiting GD3S enzyme 
activity.
• Functional characteristics of cephalothin 
analogs is currently on going. 
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Figure 2: Cephalothin displays a 6-fold dose dependent 
decrease in GD2 expression in SUM159.  
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Effect of Cephalothin on Mammosphere 
formation
Figure 1: Cephalothin inhibited mammosphere formation 
by 10-fold in SUM159 cells in a dose dependent manor. 
Figure 5: Chemical structure of (A.) Cephalothin, (B.) 
Cephalothin Analog 3, and (C.) Cephalothin Analog 6.
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